UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049619
Receipt number R000056447
Scientific Title A multicenter prospective observational study evaluating the impact of diet for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients
Date of disclosure of the study information 2022/11/26
Last modified on 2024/12/05 11:53:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective observational study evaluating the impact of diet for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients

Acronym

DIET-ICI study

Scientific Title

A multicenter prospective observational study evaluating the impact of diet for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients

Scientific Title:Acronym

DIET-ICI study

Region

Japan


Condition

Condition

Non-small cell lung cacner

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the impact of diet on the efficacy of immune checkpoint inhibitorsin patients with non-small cell lung cancer

Basic objectives2

Others

Basic objectives -Others

To clarify the correlation between various blood amino acid and fatty acid levels and the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patient

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Progression-free survival

Key secondary outcomes

1) Objective response rate
2) Overall survival
3) Immune-related adverse events


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with histologically or cytologically diagnosed non-small cell lung cancer
2. Patients who receive treatment including immune checkpoint inhibitors (monotherapy or combination therapy) as initial therapy (However, patients with driver gene mutations who have previously been treated with molecular targeted drugs are also acceptable)
3. Patients with her PS 0-2 at enrollment
4. Patients with self-determination ability over 20 years old
5. Patients with written consent

Key exclusion criteria

1. Patients under the age of 20
2. Patients who cannot consent to participate in this study
3. Patients who have insufficient decision-making ability and cannot obtain written informed consent from the patient
4. Patients who are judged to be inappropriate as research subjects by the principal investigator or co-investigator

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Takuro
Middle name
Last name Sakagami

Organization

Kumamoto University Medical Sciences

Division name

Department of Respiratory Medicine

Zip code

860-8556

Address

1-1-1 Honjo, Chuoh-Ku, Kumamoto City, Japan

TEL

096-373-5012

Email

stakuro@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name Koichi
Middle name
Last name Saruwatari

Organization

Kumamoto University Medical Sciences

Division name

Department of Respiratory Medicine

Zip code

860-8556

Address

1-1-1 Honjo, Chuoh-Ku, Kumamoto City, Japan

TEL

096-373-5012

Homepage URL


Email

ksaruwat@kuh.kumamoto-u.ac.jp


Sponsor or person

Institute

Department of Respiratory Medicine Kumamoto University Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Life Sciences, Kumamoto University

Address

1-1-1 Honjo, Chuo-ku, Kumamoto

Tel

096-373-5657

Email

ski-shien@jimu.kumamoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

熊本中央病院(熊本県),熊本市民病院(熊本県)、くまもと県北病院(熊本県)、熊本労災病院(熊本県)、人吉医療センター(熊本県)、宮崎県立延岡病院(宮崎県)


Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 09 Month 23 Day

Date of IRB

2022 Year 10 Month 27 Day

Anticipated trial start date

2022 Year 11 Month 28 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The information of diet in non-small cell lung cancer patients receiving immune checkpoint inhibitors is collected using a food intake frequency questionnaire. We investigate the clinical course after the administration immune checkpoint inhibitors in NSCLC patients who was entried this study.


Management information

Registered date

2022 Year 11 Month 26 Day

Last modified on

2024 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056447